Antibiotic susceptibility of Waddlia chondrophila in Acanthamoeba castellanii amoebae

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 6, 2009, Pages 2663-2666

  Goy, Geneviève ^a   Greub, Gilbert ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CIPROFLOXACIN; DNA; DOXYCYCLINE; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACANTHAMOEBA CASTELLANII; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM; CATTLE; CELL CULTURE; CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CHLAMYDOPHILA PSITTACI; COCULTURE; DNA SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARACHLAMYDIA ACANTHAMOEBA; PARASITE CULTIVATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPONTANEOUS ABORTION; STAPHYLOCOCCUS AUREUS; VERO CELL; WADDLIA CHONDROPHILA;

ACANTHAMOEBA CASTELLANII; ANIMALS; ANTI-BACTERIAL AGENTS; CHLAMYDIALES; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; QUINOLONES;

EID: 67049096124     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00046-09     Document Type: Article

References (28)

1. Baud, D., V. Thomas, A. Arafa, L. Regan, and G. Greub. 2007. Waddlia chondrophila, a potential agent of human fetal death. Emerg. Infect. Dis. 13:1239-1243.
2. Butaye, P., R. Ducatelle, P. De Backer, H. Vermeersch, J. P. Remon, and F. Haesebrouck. 1997. In vitro activities of doxycycline and enrofloxacin against European Chlamydia psittaci strains from turkeys. Antimicrob. Agents Chemother. 41:2800-2801.
3. Casson, N., and G. Greub. 2006. Resistance of different Chlamydia-like organisms to quinolones and mutations in the quinolone resistance-determining region of the DNA gyrase A- and topoisomerase-encoding genes. Int. J. Antimicrob. Agents 27:541-544.
4. Chirgwin, K., P. M. Roblin, and M. R. Hammerschlag. 1989. In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR). Antimicrob. Agents Chemother. 33:1634-1635.
5. Chua, P. K., J. E. Corkill, P. S. Hooi, S. C. Cheng, C. Winstanley, and C. A. Hart. 2005. Isolation of Waddlia malaysiensis, a novel intracellular bacterium, from fruit bat (Eonycteris spelaea). Emerg. Infect. Dis. 11:271-277.
6. Clinical and Laboratory Standard Institute. 2006. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. Clinical and Laboratory Standard Institute, Wayne, PA.
7. Dilbeck, P. M., J. F. Evermann, T. B. Crawford, A. C. S. Ward, C. W. Leathers, C. J. Holland, C. A. Mebus, L. L. Logan, F. R. Rurangirwa, and T. C. McGuire. 1990. Isolation of a previously undescribed rickettsia from an aborted bovine fetus. J. Clin. Microbiol. 28:814-816.
8. Dreses-Werringloer, U., I. Padubrin, H. Zeidler, and L. Kohler. 2001. Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. Antimicrob. Agents Chemother. 45:3001-3008.
9. Goy, G., A. Croxatto, and G. Greub. 2008. Waddlia chondrophila enters and multiplies within human macrophages. Microbes Infect. 10:556-562.
10. Greub, G., and D. Raoult. 2002. Crescent bodies of Parachlamydia acanthamoeba and its life cycle within Acanthamoeba polyphaga: an electron micrograph study. Appl. Environ. Microbiol. 68:3076-3084.
11. Haider, S., A. Collingro, J. Walochnik, M. Wagner, and M. Horn. 2008. Chlamydia-like bacteria in respiratory samples of community-acquired pneumonia patients. FEMS Microbiol. Lett. 281:198-202.
12. Hammerschlag, M. R., and A. Gleyzer. 1983. In vitro activity of a group of broad-spectrum cephalosporins and other β-lactam antibiotics against Chlamydia trachomatis. Antimicrob. Agents Chemother. 23:493-494.
13. Hammerschlag, M. R., C. L. Hyman, and P. M. Roblin. 1992. In vitro activities of five quinolones against Chlamydia pneumoniae. Antimicrob. Agents Chemother. 36:682-683.
14. Hammerschlag, M. R., K. K. Qumei, and P. M. Roblin. 1992. In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae. Antimicrob. Agents Chemother. 36:1573-1574.
15. Henning, K., G. Schares, H. Granzow, U. Polster, M. Hartmann, H. Hotzel, K. Sachse, M. Peters, and M. Rauser. 2002. Neospora caninum and Waddlia chondrophila strain 2032/99 in a septic stillborn calf. Vet. Microbiol. 85:285-292.
16. Kuo, C. C., and J. T. Grayston. 1988. In vitro drug susceptibility of Chlamydia sp. strain TWAR. Antimicrob. Agents Chemother. 32:257-258.
17. Kuo, C. C., L. A. Jackson, A. Lee, and J. T. Grayston. 1996. In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae. Antimicrob. Agents Chemother. 40:2669-2670.
18. Maurin, M., A. Bryskier, and D. Raoult. 2002. Antibiotic susceptibilities of Parachlamydia acanthamoeba in amoebae. Antimicrob. Agents Chemother. 46:3065-3067.
19. Miyashita, N., H. Fukano, K. Yoshida, Y. Niki, and T. Matsushima. 2002. In vitro activity of moxifloxacin and other fluoroquinolones against Chlamydia species. J. Infect. Chemother. 8:115-117.
20. Miyashita, N., Y. Niki, T. Kishimoto, M. Nakajima, and T. Matsushima. 1997. In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp. Antimicrob. Agents Chemother. 41:1331-1334. (Pubitemid 27231437)
21. Nakamura, S. 1997. Mechanisms of quinolone resistance. J. Infect. Chemother. 3:128-138.
22. Nilius, A. M., L. L. Shen, D. Hensey-Rudloff, L. S. Almer, J. M. Beyer, D. J. Balli, Y. Cai, and R. K. Flamm. 2003. In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinolone. Antimicrob. Agents Chemother. 47:3260-3269.
23. Raoult, D., F. Fenollar, and A. Stein. 2002. Q fever during pregnancy: diagnosis, treatment, and follow-up. Arch. Intern. Med. 162:701-704.
24. Rurangirwa, F. R., P. M. Dilbeck, T. B. Crawford, T. C. McGuire, and T. F. McElwain. 1999. Analysis of the 16S rRNA gene of micro-organism WSU 86-1044 from an aborted bovine foetus reveals that it is a member of the order Chlamydiales: proposal of Waddliaceae fam. nov., Waddlia chondrophila gen. nov., sp. nov. Int. J. Syst. Bacteriol. 49:577-581. (Pubitemid 129755056)
25. Samra, Z., S. Rosenberg, Y. Soffer, and M. Dan. 2001. In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines. Diagn. Microbiol. Infect. Dis. 39:177-179.
26. Senn, L., M. R. Hammerschlag, and G. Greub. 2005. Therapeutic approaches to Chlamydia infections. Expert Opin. Pharmacother. 6:2281-2290.
27. Smelov, V., T. Krylova, N. Smelova, and L. Norman. 2004. Azithromycin treatment follow-up: antibacterial susceptibility of Chlamydia trachomatis in patients with chronic prostatitis. Int. J. Antimicrob. Agents 23(Suppl. 1):S79-S82.
28. Suchland, R. J., W. M. Geisler, and W. E. Stamm. 2003. Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp. Antimicrob. Agents Chemother. 47:636-642. (Pubitemid 36158094)